Publications
- Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis2021 | First Faculty of Medicine
- Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis2021 | First Faculty of Medicine
- Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study2020 | First Faculty of Medicine
- Interest in Telerehabilitation Among Patients with Mild to Severe Multiple Sclerosis: Results of the Czech Republic2024 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?2024 | First Faculty of Medicine
- Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis2024 | First Faculty of Medicine
- Prognostic value of single-subject grey matter networks in early multiple sclerosis2024 | First Faculty of Medicine
- CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS2023 | First Faculty of Medicine, Third Faculty of Medicine
- Data analytics framework for sparse longitudinal structured biomedical data2023 | First Faculty of Medicine, Faculty of Mathematics and Physics
Loading network view...